| INTRODUCTION
Cognitive dysfunction across attention, memory, and executive function is a core feature of bipolar disorder (BD), which persists after clinical remission from mood episodes and impedes patients' functional recovery.
1,2 Unaffected first-degree relatives of patients with BD display similar non-specific, albeit generally milder, cognitive deficits, 3 indicating that cognitive dysfunction is associated with genetic liability for BD. Functional magnetic resonance imaging (fMRI) studies of BD patients and high-risk groups show consistently that the cognitive deficits are accompanied by aberrant (hypo-and hyper-) activity in the dorsolateral and medial prefrontal cortex (dlPFC and mPFC) during working memory (WM) performance. [4] [5] [6] [7] [8] [9] [10] [11] Nevertheless, there is little understanding of the association between cognitive deficits, abnormal neural activity, and genetic liability for BD.
A risk gene encoding the enzyme catechol-O-methyltransferase (COMT) has attracted attention as a common candidate gene for both neuropsychiatric illness and cognitive dysfunction. 12 The functional Val158Met polymorphism (rs4680) of the COMT gene mediates the degradation of dopamine (DA) in the synaptic cleft, and its Val allele seems to be associated with lower levels of synaptic DA in the PFC, while the Met allele is related to higher PFC DA levels. 13 Evidence from animal and human studies suggests that hyper-and hypodopaminergic states contribute to mania and depression, respectively (eg, 14, 15) . Thus, an increase of synaptic DA levels can create manic phenotypes (eg, 16). Conversely, psychotropics that cause DA depletion can induce a depressed state (eg, 17, 18) , whereas the DA agonist pramipexole attenuates depressive symptoms in depressed BD patients. [19] [20] [21] The relationship between DA activity in the PFC and cognitive performance has been described as an inverted U-shape, in which both high and low cortical DA tonus is associated with cognitive impairments. 22 Indeed, there is relatively consistent evidence from studies on schizophrenia and healthy samples for poorer cognitive function in Val homozygotes (with low PFC DA tonus) relative to Met carriers, particularly within the executive function domain, 12, [23] [24] [25] [26] although some studies found no such association. [27] [28] [29] At the neural level, the Val allele (particularly Val homozygosity) is associated with exaggerated dlPFC activity during n-back WM across patients with schizophrenia and healthy individuals where no behavioral impairments are observed. 13, [30] [31] [32] [33] [34] [35] This evidence has led to the hypothesis of inefficient prefrontal processing in Val homozygotes, as reflected by a need to recruit greater dlPFC resources to maintain normal task performance. 36, 37 Despite evidence linking the COMT Val158Met genotype to neural and cognitive impairments, its influence on neurocognitive function in BD is unclear. One study found that cognitive dysfunction in patients with BD type I is modulated by the presence of a Val allele, with
Val carriers (n=54) exhibiting lower deficits in executive function and verbal fluency relative to Met homozygotes (n=18) during manic and mixed episodes. 38 Another study found no effect of the Val allele on attention, verbal memory, or executive function in 52 clinically stable patients with BD type I, 39 although a second functional polymorphism within COMT (rs165599) was found to influence verbal memory.
However, no neuroimaging study has investigated the association between COMT Val158Met and WM-related neural response in BD, which could provide a more sensitive assay of abnormal brain function than behavioral measures. 40, 41 The present fMRI study therefore aimed to investigate whether the COMT Val158Met polymorphism modulates dlPFC activity during the spatial n-back WM task and WM performance in remitted patients with BD. We hypothesized that Val homozygous remitted BD patients would exhibit (i) greater dlPFC activity during high-load n-back WM and (ii) impaired performance on a spatial WM test relative to Met carriers.
| METHODS

| Study design and participants
The study included baseline data from patients with BD recruited for two randomized intervention studies targeting cognitive dysfunction. 42 
| Genotyping
Genomic DNA was extracted from blood samples using the Maxwell Blood DNA purification kit (Promega, Madison, WI, USA) in accordance with the manufacturer's protocol and genotyped using the Illumina Infinium PsychArrayBeadChip (Illumina, San Diego, CA, USA).
| Neurocognitive tests
N-back WM tasks were employed as they are widely used to probe memory aspects of executive function. 45 During fMRI, participants performed a spatial n-back WM task. 46 The task consisted of blocks of three types of conditions that differed in terms of WM load (0-back, 1-back and 2-back). In each condition, a yellow circle appeared in a sequence of 14 appearances at random locations in a 5 by 5 grid. The circle was displayed for 300 ms followed by an empty grid for 1200 ms. ). This task was selected for the present study because it probes similar aspects of WM to the spatial n-back WM paradigm administered inside the scanner, thus providing a sensitive behavioral read-out of spatial WM. Moreover, we were interested in the domain of WM more specifically due to prior reported effects of COMT on this domain. Behavioral outcome measures of interest were the 'between errors' score, as indicated by the number of errors made (i.e., on 4−8 boxes), and the 'strategy' score, specifying the number of times inefficient search strategies were used. To investigate the hypothesis that the COMT Val158Met genotype would modulate spatial WM-relevant activity in the PFC, we defined a spherical region of interest (ROI) with a 10 mm radius around the peak of the right dlPFC (x=40, y=34, z=29) involved in spatial WM processes as reported in a meta-analysis. 45 The ROI was constructed on the MNI template using the WFU PickAtlas toolbox. 49 We extracted We also carried out a whole-brain exploratory analysis. Individual subject data were computed using the general linear model with local autocorrelation correction. 50 The individual contrasts of interest (2-back>1-back or 2-back>0-back) were included in separate general linear models with nonparametric permutation inference (n=5000) using the 'randomize' algorithm implemented in FSL. 51 The main effect of COMT genotype was assessed using an F test. Significant clusters were identified using the threshold-free cluster enhancement method at corrected P<.05. The mean percent BOLD signal change in clusters showing significant differences between groups was extracted for visualization purposes. A standard anatomical atlas 52 was used to localize peak cluster activations.
| Magnetic resonance imaging
| fMRI data analysis
| Statistical analyses of behavioral and mood data
For the spatial n-back WM task, signal detection theory was applied to obtain a measure of spatial n-back WM accuracy corrected for participants' response tendency (d'). 53 Outliers, defined as WM accuracy of ≥2 SD below the sample's mean, were excluded. The influence of COMT genotype on spatial n-back WM performance (accuracy and speed) during scanning was examined with WM load 1,2 as the within-subject factor and genotype (ValVal, ValMet or MetMet) as the between-subject factor (all tests were two-tailed). Significant interactions were followed up by independent-samples t tests. 
| RESULTS
| Patient characteristics
| Behavioral results
The WM accuracy (d') score data showed a negative skew due to near-ceiling accuracy rates. As d' scores are in the range of 0−1, we arcsine transformed the data to approach a normal distribution prior Figure 2 ). This interaction remained statistically significant after adjustment for age (P=.032) and was reduced to a strong trend after adjustment for illness duration (P=.051). Notably, the lower dlPFC activity in ValVal individuals during high-load specific
WM was also observed in post hoc comparison of ValVal individuals with all Met carriers (MetMet and ValMet) (t=2.81, df= 62, P=.007).
No significant effects of COMT genotype and gender were found on high-load specific dlPFC activity (P>.99).
| Whole-brain exploratory analyses
High-load specific (2-back>1-back) WM activated a widespread frontoparietal network of overlapping regions, including the right and left dlPFC (for peak cluster activations, see Table 3 ), consistent with the literature.
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Exploratory whole-brain analyses revealed no effect of genotype for either high-load specific or general WM (F tests assessing possible differences between genotype groups). Prompted by our ROI finding, we also 
| Associations between mood, medication, BOLD response and behavior
Across the entire sample, subsyndromal mania and depression symptoms showed no correlation with high-load specific dlPFC activ- 
| DISCUSSION
The present fMRI study examined the effects of the functional COMT Val158Met polymorphism on WM-related neural activity in partially or fully remitted BD patients. Based on previous studies of schizophrenia and healthy groups, 37 we had hypothesized that Val homozygous BD patients would exhibit increased activity in the dlPFC during high-load WM relative to Met carriers. Contrary to our predictions, Val homozygous patients showed decreased dlPFC activity during high-load WM compared with Met carriers. We observed no effect of genotype on n-back WM performance during the scan. However, as hypothesized,
Val carriers displayed poorer performance than Met homozygotes on the CANTAB SWM task outside the scanner, as reflected by less efficient strategies and more errors (effect sizes: Cohen's d=0.98−1.90).
The observed effects of genotype on WM-related neural activity and spatial WM performance in our BD cohort occurred in the absence of differences between genotypes in demographic characteristics, subsyndromal mood symptoms or medications.
The relatively reduced dlPFC activity during high-load specific WM in Val homozygous patients was unexpected given evidence pointing to hyperactivity and purported inefficient dlPFC function in Val carriers. 13, [30] [31] [32] [33] [34] [35] However, it is conceivable that Val homozygous patients' lower dlPFC activity reflects failure to recruit task-relevant dlPFC resources, given their impaired performance on the CANTAB SWM task. Indeed, decreased right dlPFC activity during high WM loads in
Val homozygous patients with BD is consistent with the literature on Notably, this association between COMT genotype and dlPFC activity was rendered non-significant in a post hoc analysis adjusted for illness duration (P=.051). While the sample size is small, this could suggest that presumed progressive cognitive decline with more chronic illness weakens the association between COMT genotype and dlPFC function in BD.
The demonstration of no behavioral difference between COMT genotype groups on the n-back WM task is in line with previous research utilizing this test in psychiatric and healthy populations.
27-29
This finding is likely to reflect a ceiling effect attributable to high nback WM accuracy in all participants (i.e., 89% accuracy across all genotype groups) given (i) the significant correlation between performance on the n-back WM and SWM tests, indicating that the two tests measure the same construct (i.e., spatial WM) and (ii) the separation between groups on performance on the (more difficult) CANTAB SWM test outside the scanner. Indeed, prior evidence suggests that accuracy is generally high in the n-back paradigm and that WM loads ─ even when including three items ─ fail to yield differences in performance between the COMT Val158Met genotypes. 27 Nevertheless, the n-back task is arguably the most commonly used fMRI paradigm in the assessment of neural underpinnings of executive function and is optimized for delineating task-relevant neural activity precisely because it ensures high performance accuracy (i.e., neural activity subserving correct performance). The task should thus be combined with more demanding WM tasks devoid of ceiling effects outside the scanner to optimize sensitivity for differences in behavioral read-outs.
Previous research in patients with schizophrenia and healthy individuals has shown that Val homozygotes exhibit exaggerated WMrelated activity in the dlPFC in the absence of behavioral differences.
Increased PFC activity has therefore been hypothesized to indicate reduced neural efficiency. 27 However, the decreased dlPFC activity in
Val homozygous BD patients may also be indicative of less efficient recruitment of WM-related neural resources, which could explain these individuals' poorer performance on the SWM test outside the scanner. Indeed, task-related dlPFC hypoactivity in BD has been hypothesized to play a key role in patients' common deficits in attention control and decision making. 
